Iceland· IS-EU/1/14/960/001
DUAVIVE
A conjugated estrogens and bazedoxifene product containing bazedoxifenum inn asetat,estrogens conjugated, registered in Iceland by Pfizer Europe MA EEIG*. The same ATC class is registered in 8 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Conjugated estrogens and bazedoxifene is registered in 8 of 19 countries.
Countries holding a registration under ATC G03CC07 (conjugated estrogens and bazedoxifene), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 5 of them publish a price we can compare per daily dose
Conjugated estrogens and bazedoxifene · ATC G03CC07
8 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Polandprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Bazedoxifenum INN asetat,Estrogens conjugated
- Manufacturer
- Pfizer Europe MA EEIG*
- Country
- Iceland (IS)
- ATC code
- G03CC07
- ATC class
- Conjugated estrogens and bazedoxifene
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Conjugated estrogens and bazedoxifene in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDuaveeWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- CzechiaDUAVIVEPfizer Europe MA EEIG, Bruxelles
- SpainDUAVIVE 0,45 MG/20 MG COMPRIMIDOS DE LIBERACION MODIFICADAPfizer Europe Ma Eeig
- FinlandDUAVIVEPfizer Europe MA EEIG
- United KingdomDuavive 0.45mg/20mg modified-release tabletsPfizer Ltd
- CanadaDUAVIVEPFIZER CANADA ULC
- NetherlandsDuavive, 20 mg/ 0.45 mg tablet met gereguleerde afgiftePfizer Europe MA EEIG
- PolandDuavivePfizer Europe MA EEIG
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Duavive
- Norway · Duavive
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7659fd3c-f652-43d1-8e08-9444a180572a GET /v1/drugs/7659fd3c-f652-43d1-8e08-9444a180572a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tafla með breyttan losunarhraða",
"source": "lyfjastofnun",
"atc_raw": "G03CC07",
"marketed": false,
"strength": "0,45 mg/20 mg",
"ma_number": "EU/1/14/960/001",
"substance": "Bazedoxifenum INN asetat,Estrogens conjugated",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "41989"
}See everything about conjugated estrogens and bazedoxifene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.